These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2418841)
1. Demonstration of cell sidedness in hepatic transfer of morphine and morphine glucuronide in the rat. Berman EF; Fujimoto JM Biochem Pharmacol; 1986 Feb; 35(3):479-86. PubMed ID: 2418841 [TBL] [Abstract][Full Text] [Related]
2. Morphine-morphine glucuronide pools in the rat liver: effects of Triton X-100. Sweeney EF; Fuhrman-Lane C; Fujimoto JM J Pharmacol Exp Ther; 1984 Jan; 228(1):19-27. PubMed ID: 6694102 [TBL] [Abstract][Full Text] [Related]
3. Trans-stilbene oxide administration increased hepatic glucuronidation of morphine but decreased biliary excretion of morphine glucuronide in rats. Fuhrman-Lane C; Fujimoto JM J Pharmacol Exp Ther; 1982 Sep; 222(3):526-33. PubMed ID: 6809929 [TBL] [Abstract][Full Text] [Related]
4. The effect of pregnancy and estradiol-17 beta treatment on the biliary transport maximum of dibromosulfophthalein, and the glucuronide conjugates of 5-phenyl-5-p-hydroxyphenyl[14C]hydantoin and [14C]morphine in the isolated perfused rat liver. Auansakul AC; Vore M Drug Metab Dispos; 1982; 10(4):344-9. PubMed ID: 6126332 [TBL] [Abstract][Full Text] [Related]
5. Site of action of dehydrocholate in inhibiting the biliary excretion of morphine in the isolated in situ perfused rat liver. Imamura T; Fujimoto JM J Pharmacol Exp Ther; 1980 Oct; 215(1):116-21. PubMed ID: 7452477 [TBL] [Abstract][Full Text] [Related]
6. The disposition of morphine and its metabolites in the in-situ rat isolated perfused liver. Evans AM; Shanahan K J Pharm Pharmacol; 1995 Apr; 47(4):333-9. PubMed ID: 7791033 [TBL] [Abstract][Full Text] [Related]
7. Application of a loading wash-out method for investigating the hepatocellular efflux of a hepatically-generated metabolite, morphine-3-glucuronide. Evans AM; O'Brien J; Nation RL J Pharm Pharmacol; 1999 Nov; 51(11):1289-97. PubMed ID: 10632087 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the inhibition of biliary excretion produced by certain inducing agents including 2,3,7,8-tetrachlorodibenzo-p-dioxin. Berman EF; Schaus P; Fujimoto JM J Toxicol Environ Health; 1986; 17(4):395-403. PubMed ID: 2421000 [TBL] [Abstract][Full Text] [Related]
9. Chlordecone pretreatment alters [14C]chlordecone and [14C]cholesterol transport kinetics in the perfused rat liver. Gilroy DJ; Carpenter HM; Curtis LR Fundam Appl Toxicol; 1994 Feb; 22(2):286-92. PubMed ID: 7516299 [TBL] [Abstract][Full Text] [Related]
10. Transport is not rate-limiting in morphine glucuronidation in the single-pass perfused rat liver preparation. Doherty MM; Poon K; Tsang C; Pang KS J Pharmacol Exp Ther; 2006 May; 317(2):890-900. PubMed ID: 16464965 [TBL] [Abstract][Full Text] [Related]
11. Hepatic morphine and estrone glucuronyltransferase activity and morphine biliary excretion in the isolated perfused rat liver. Effect of pregnancy and estradiol-17 beta treatment. Brock WJ; Vore M Drug Metab Dispos; 1982; 10(4):336-43. PubMed ID: 6126331 [TBL] [Abstract][Full Text] [Related]
12. Evidence for reversible sequestration of morphine in rat liver. Matheny CJ; Taft DR; Brouwer KL; Pollack GM Biochem Pharmacol; 1996 Aug; 52(4):535-41. PubMed ID: 8759025 [TBL] [Abstract][Full Text] [Related]
13. The disposition of morphine and morphine-3-glucuronide in the isolated perfused rat liver: effects of altered perfusate flow rate. O'Brien JA; Nation RL; Evans AM J Pharm Pharmacol; 1996 May; 48(5):498-504. PubMed ID: 8799874 [TBL] [Abstract][Full Text] [Related]
14. A new mode of action of SKD 525-A on morphine disposition studied by segmented retrograde intrabiliary injection (SRII) in the isolated in situ perfused rat liver. Imamura T; Fujimoto JM J Pharmacol Exp Ther; 1980 Oct; 215(1):122-6. PubMed ID: 7452478 [TBL] [Abstract][Full Text] [Related]
15. Effects of albumin on the disposition of morphine and morphine-3-glucuronide in the rat isolated perfused liver. O'Brien JA; Evans AM; Nation RL Clin Exp Pharmacol Physiol; 1997 Feb; 24(2):143-8. PubMed ID: 9075586 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of 14C-codeine in the isolated, perfused rat liver. Christensen CB; Jansen JA; Ravn-Jonsen A; Reiff L Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):134-40. PubMed ID: 6711321 [TBL] [Abstract][Full Text] [Related]
17. Studies of the enterohepatic circulation of morphine in the rat. Walsh CT; Levine RR J Pharmacol Exp Ther; 1975 Nov; 195(2):303-10. PubMed ID: 1185599 [TBL] [Abstract][Full Text] [Related]
18. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide). Vore M; Durham S; Yeh S; Ganguly T Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901 [TBL] [Abstract][Full Text] [Related]
19. The effect of estradiol-17 beta treatment on the metabolism and biliary excretion of phenytoin in the isolated perfused rat liver and in vivo. Vore M; Montgomery C J Pharmacol Exp Ther; 1980 Oct; 215(1):71-6. PubMed ID: 7452491 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of morphine metabolism by ketamine. Qi X; Evans AM; Wang J; Miners JO; Upton RN; Milne RW Drug Metab Dispos; 2010 May; 38(5):728-31. PubMed ID: 20124399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]